Pair Name | Icaritin, TNF-related apoptosis inducing ligand | ||
Phytochemical Name | Icaritin (PubChem CID: 5318980 ) | ||
Anticancer drug Name | TNF-related apoptosis inducing ligand (PubChem CID: / ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Icaritin, TNF-related apoptosis inducing ligand | |||
Disease Info | [ICD-11: 2A00] | Glioblastoma multiforme | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Up-regulation | Cleavage | CASP3 | hsa836 |
Down-regulation | Expression | CFLAR | hsa8837 | |
Up-regulation | Cleavage | PARP1 | hsa142 | |
Down-regulation | Expression | RELA | hsa5970 | |
In Vitro Model | U-373MG ATCC | Astrocytoma | Homo sapiens (Human) | CVCL_2219 |
U-87MG ATCC | Glioblastoma | Homo sapiens (Human) | CVCL_0022 | |
Result | These data suggest that icaritin sensitizes TRAIL-induced tumor cell apoptosis via suppression of NF-κB-dependent c-FLIP expression, providing in vitro evidence supporting the notion that icaritin is a potential sensitizer of TRAIL in anticancer therapy against human GBM. |
No. | Title | Href |
---|---|---|
1 | Icaritin Sensitizes Human Glioblastoma Cells to TRAIL-Induced Apoptosis. Cell Biochem Biophys. 2015 Jun;72(2):533-42. doi: 10.1007/s12013-014-0499-y. | Click |